XML 43 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Reporting
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment Reporting

Note 20 Segment Reporting

Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

 

Automotive — this segment represents the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems.

 

Medical this segment represents the combined results from our Medical business, GPT (through October 1, 2019), CSZ-IC (through February 1, 2019) and non-automotive expenses from Gentherm’s advanced research and development division (through December 31, 2019). The operating results from these businesses and division are presented together as one reporting segment because of their historical joint concentration on identifying new markets and product applications based on thermal management technologies. With the remaining temperature management business being the primary focus now in this segment, we have renamed it to reflect the strategic direction of this segment.

 

Corporate — includes corporate costs, selling, general and administrative costs and acquisition transaction costs. This segment has been renamed this year to better align with the costs allocated to this segment.  It was previously named ‘Reconciling Items’.

In 2018 and 2019, our Industrial reporting segment represented the combined results from our patient temperature management systems business, GPT (through its divestiture on October 1, 2019), CSZ-IC (through its divestiture on February 1, 2019) and non-automotive expenses from our advanced research and development division (through December 31, 2019). The operating results from these businesses and division previously were presented together as one reporting segment because of their historical joint concentration on identifying new markets and product applications based on thermal management technologies.

In 2020, the Industrial reporting segment was renamed the Medical reporting segment to reflect the patient temperature management business as the focus and strategic direction of this segment. Also, during 2020, the advanced research and development costs not associated with the Medical segment were moved to the Automotive segment, as this organization now primarily supports the Automotive related development activities following the divestitures of GPT and CSZ-IC.  For comparability to the prior years, we have moved the portion of advanced research and development costs to the Automotive segment that were focused on technologies related to automotive in 2018 and 2019 in both the Depreciation and amortization and Operating income (loss) lines in the table below.

The tables below present segment information about the reported product revenues and operating income of the Company for years ended December 31, 2020, 2019 and 2018. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level.

 

 

 

Automotive

 

 

Medical

 

 

Corporate

 

 

Total

 

2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

869,998

 

 

$

43,100

 

 

$

 

 

$

913,098

 

Depreciation and amortization

 

 

37,662

 

 

 

2,366

 

 

 

1,086

 

 

$

41,114

 

Operating income (loss)

 

 

138,410

 

 

 

971

 

 

 

(50,164

)

 

$

89,217

 

2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

920,225

 

 

$

51,459

 

 

$

 

 

$

971,684

 

Depreciation and amortization

 

 

40,923

 

 

 

1,621

 

 

 

1,702

 

 

$

44,246

 

Operating income (loss)

 

 

141,206

 

 

 

(5,735

)

 

 

(51,211

)

 

$

84,260

 

2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

957,824

 

 

$

90,681

 

 

$

 

 

$

1,048,505

 

Depreciation and amortization

 

 

44,246

 

 

 

3,759

 

 

 

2,633

 

 

$

50,638

 

Operating income (loss)

 

 

136,421

 

 

 

(6,900

)

 

 

(56,733

)

 

$

72,788

 

 

 

Automotive and Medical segment product revenues by product category for each of the years ended December 31, 2020, 2019 and 2018 are as follows:

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Climate Control Seat (CCS)

 

$

342,550

 

 

$

359,355

 

 

$

373,945

 

Seat Heaters

 

 

249,665

 

 

 

284,174

 

 

 

305,337

 

Steering Wheel Heaters

 

 

76,272

 

 

 

65,426

 

 

 

69,845

 

Automotive Cables

 

 

73,997

 

 

 

88,031

 

 

 

98,931

 

Electronics

 

 

53,238

 

 

 

47,542

 

 

 

56,783

 

Battery Performance Solutions (BPS)(a)

 

 

50,901

 

 

 

41,498

 

 

 

28,472

 

Other Automotive

 

 

23,375

 

 

 

34,199

 

 

 

24,511

 

Subtotal Automotive segment

 

 

869,998

 

 

 

920,225

 

 

 

957,824

 

Medical

 

 

43,100

 

 

 

36,860

 

 

 

30,108

 

GPT

 

 

 

 

 

11,181

 

 

 

19,520

 

CSZ-IC

 

 

 

 

 

3,418

 

 

 

41,053

 

Subtotal Medical segment

 

 

43,100

 

 

 

51,459

 

 

 

90,681

 

Total Company

 

$

913,098

 

 

$

971,684

 

 

$

1,048,505

 

 

(a)

Battery Performance Solutions (BPS) was renamed from Battery Thermal Management (BTM), to better represent our product offerings included within this product category.

 

 

Revenue (based on shipment destination) by geographic area for each of the years ended December 31, 2020, 2019 and 2018 is as follows:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

United States

 

$

377,577

 

 

$

440,316

 

 

$

488,926

 

China

 

 

101,039

 

 

 

71,461

 

 

 

93,628

 

South Korea

 

 

88,745

 

 

 

63,339

 

 

 

58,717

 

Germany

 

 

58,536

 

 

 

81,315

 

 

 

88,366

 

Japan

 

 

57,785

 

 

 

76,197

 

 

 

62,633

 

Czech Republic

 

 

37,542

 

 

 

38,888

 

 

 

42,665

 

Other

 

 

191,874

 

 

 

200,168

 

 

 

213,570

 

Total Non-U.S.

 

 

535,521

 

 

 

531,368

 

 

 

559,579

 

Total Company

 

$

913,098

 

 

$

971,684

 

 

$

1,048,505

 

 

The table below lists the percentage of total product revenues generated from sales to customers which contributed 10% or more to the Company’s total consolidated product revenue for the years ended December 31, 2020, 2019 and 2018:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Lear

 

 

15

%

 

 

16

%

 

 

17

%

Adient

 

 

14

%

 

 

15

%

 

 

16

%

 

Property and equipment, net, for each of the geographic areas in which the Company operates as of December 31, 2020 and 2019 is as follows:

 

 

 

 

 

 

 

 

 

December 31,

 

Property and equipment, net

 

2020

 

 

2019

 

Macedonia

 

$

38,273

 

 

$

38,989

 

Vietnam

 

 

21,080

 

 

 

21,452

 

China

 

 

20,375

 

 

 

23,721

 

United States

 

 

19,011

 

 

 

21,280

 

Mexico

 

 

16,034

 

 

 

19,982

 

Germany

 

 

15,641

 

 

 

10,515

 

Ukraine

 

 

9,364

 

 

 

11,727

 

Hungary

 

 

8,401

 

 

 

6,803

 

Other

 

 

4,402

 

 

 

6,136

 

Total

 

$

152,581

 

 

$

160,605